Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Katelyn Ann Pastick, M.D.

Concepts (78)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Meningitis, Cryptococcal52021651.320 Why?
Hydroxychloroquine520214310.450 Why?
Postpartum Period1202012050.410 Why?
Disease Management1202025350.320 Why?
Post-Exposure Prophylaxis220201130.320 Why?
Cryptococcus22019280.310 Why?
Pregnancy Complications, Infectious1202021870.290 Why?
Fluconazole420221540.290 Why?
Amphotericin B320201400.250 Why?
Uganda5202213530.250 Why?
Lamivudine220223680.190 Why?
Benzoxazines220223200.190 Why?
Antifungal Agents320207690.180 Why?
HIV Infections62022175330.170 Why?
Deoxycholic Acid12020540.170 Why?
Pandemics4202087030.170 Why?
Adjuvants, Pharmaceutic12019480.160 Why?
Cryptococcus neoformans120201100.160 Why?
AIDS-Related Opportunistic Infections220216640.160 Why?
Coronavirus Infections3202031000.150 Why?
Pneumonia, Viral3202032230.150 Why?
Sertraline120192090.150 Why?
Antigens, Fungal12018690.140 Why?
Immunoassay120187410.110 Why?
Drug Combinations1202020770.110 Why?
Outpatients1202015950.100 Why?
Alcoholism1202119750.090 Why?
CD4 Lymphocyte Count3202225870.090 Why?
Anti-HIV Agents1202245590.070 Why?
Double-Blind Method42020124370.060 Why?
Canada2202121190.060 Why?
Clinical Trials as Topic1202080410.060 Why?
Genitalia, Female120221470.050 Why?
Clinical Trials, Phase IV as Topic12021300.050 Why?
Postmortem Changes120191190.040 Why?
Chromatography, Liquid120229900.040 Why?
Autopsy1202210110.040 Why?
Delayed Diagnosis120224520.040 Why?
Alkynes120193260.040 Why?
Pregnancy12020302600.040 Why?
Cyclopropanes120194370.040 Why?
Cerebrospinal Fluid120205390.040 Why?
Inhalation Exposure120204320.040 Why?
Female920223961120.030 Why?
Adult620212230440.030 Why?
Humans1420227659680.030 Why?
Tandem Mass Spectrometry1202211920.030 Why?
South Africa1202118670.030 Why?
Prospective Studies12020548020.030 Why?
Hemoglobins1202115300.030 Why?
Multicenter Studies as Topic1202017310.030 Why?
Social Stigma120217880.030 Why?
Treatment Failure1202026520.030 Why?
Creatinine1201919150.030 Why?
Antimalarials120209130.030 Why?
Young Adult12020598890.030 Why?
Brain12019271710.020 Why?
Social Support1202221920.020 Why?
Anemia1202115110.020 Why?
Adolescent12020888350.020 Why?
Male720223636980.020 Why?
Qualitative Research1202131390.020 Why?
Occupational Exposure1202018050.020 Why?
Health Personnel1202133900.020 Why?
Sex Factors12021106030.020 Why?
Proportional Hazards Models12021125090.020 Why?
Cost-Benefit Analysis1201955260.020 Why?
Cytokines1202174210.020 Why?
Risk Factors22021748400.010 Why?
Severity of Illness Index12020158800.010 Why?
Middle Aged320202230090.010 Why?
Retrospective Studies22020815140.010 Why?
Follow-Up Studies12020391930.010 Why?
Time Factors12020400650.010 Why?
Cohort Studies12021416490.010 Why?
Treatment Outcome12019651880.010 Why?
United States12020729030.010 Why?
Aged120181711170.000 Why?
Pastick's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (78)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.